is glp-1 safe for breast cancer survivors Receptor Agonists Linked to Improved Survival Outcomes in GLP-1 medications may improve survival

By combining sleep data with cognitive assessments, researchers can detect subtle cognitive changes earlier and gain clearer insights into treatment efficacy

Effect of DHT-induced hyperandrogenism on the pro-inflammatory cytokines in a rat model of polycystic ovary morphology

Additional outcomes, including the pathological complete response (pCR), were studied in a retrospective analysis of 347 patients with earlystage triplenegative breast cancer (TNBC) who received KEYNOTE522 and GLP1 RAs or DPP4i treatment at diagnosis and throughout the neoadjuvant period

K.BrowneJ

Technically yes, but the risk profile changes significantly

Understanding how these medications affect body composition, what clinical trials reveal about waist circumference changes, and how to maximize results through lifestyle modifications helps patients set realistic expectations for their weight management journey